Author:
Ravandi Farhad,Cortes Jorge
Reference210 articles.
1. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group;Abu-Duhier;Br. J. Haematol,2000
2. Proteasome inhibitors: A novel class of potent and effective antitumor agents;Adams;Cancer Res,1999
3. Blocking oncogenic Ras signaling for cancer therapy;Adjei;J. Natl. Cancer. Inst,2001
4. A Phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity;Adjei;Cancer Res,2000
5. Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC);Advani;Adv. Exp. Med. Biol,1999